Transcat Announces Appointment of Roy Simmons as Chief Strategy and Corporate Development Officer
Proven B2B Leader Brings Over Two Decades of Experience Driving Strategy, Corporate Development, and Value Creation Across Global Markets
Transcat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leading provider of test measurement, control and calibration, today announced the appointment of Roy Simmons as Chief Strategy and Corporate Development Officer ("CSCDO"). In this newly created executive role, Simmons will report to the CEO and serve as a core member of Transcat’s executive leadership team.
As Chief Strategy and Corporate Development Officer, Mr. Simmons will be responsible for shaping and executing Transcat’s enterprise-wide growth strategy. This includes leading corporate strategy development, overseeing the full M&A lifecycle, and ensuring strong alignment between long-term strategy and operational execution.
"We are thrilled to welcome Roy to Transcat. Roy’s track record of delivering exceptional performance across multiple industries, extensive M&A experience, and his ability to test and build differentiated B2B strategies at scale make him a great addition to our leadership team," said Jaime Irick, President and Chief Executive Officer of Transcat. "Roy’s core values, collaborative leadership style, and relentless focus on delivering customer value are well suited to our Transcat culture – a culture which we view as a competitive advantage in the marketplace."
Mr. Simmons brings over two decades of global leadership experience spanning strategy, corporate development, finance, and operations across complex, publicly traded, and high-growth organizations. Most recently, he served as President and General Manager of Pear Health Labs, where he built a personalized wellness platform and positioned the company to grow at scale through the creation of a differentiated product roadmap, enhanced commercial capabilities, and disciplined financial strategy.
Mr. Simmons previously held leadership positions at Savant Systems, Inc., including leading the company’s Power Business and driving growth and strategic initiatives across the portfolio. Prior to that, Mr. Simmons served as Executive Vice President and Chief Financial Officer of GE Lighting, where he delivered significant margin expansion and improved EBITDA and cash flow performance while helping establish the business as a successful standalone entity following its separation from General Electric. He has also served as VP, Business Development at Life Fitness where he formed the M&A strategy and led large-scale strategic transactions, including the $490 million sale of Life Fitness.
Throughout his career, Mr. Simmons has demonstrated a consistent track record of leading high-performing teams, executing complex transactions, and driving sustainable growth through disciplined strategy and operational excellence. He has also led multiple processes to develop and execute a strategic acquisition framework which includes a disciplined approach to core and adjacent space transactions.
Mr. Simmons commented, "It is an honor to join Transcat and its talented team of employees. With a diversified portfolio of products and services, Transact is already established as the leader in the calibration services market, with recurring revenue streams and solid runway for organic growth and disciplined consolidation. I look forward to partnering with Jaime and the senior leadership team to advance the Company's strategic priorities, pursue opportunities for both organic and inorganic growth, and further strengthen the value we deliver to customers and shareowners. I am excited about the future and the significant opportunities that lie ahead for Transcat."
This appointment reflects Transcat’s continued commitment to advancing its long-term growth strategy, enhancing shareholder value, and strengthening its transformational leadership position in a growing and dynamic market environment.
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its Calibration Service Centers strategically located across the United States and Internationally. In addition, Transcat operates calibration labs in imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.
Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity create a unique and compelling value proposition for its customers.
Transcat’s strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, Cost, Control and Optimizations services, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at Transcat.com.
Safe Harbor Statement
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and assumptions. Forward-looking statements relate to expectations, estimates, beliefs, assumptions and predictions of future events and are identified by words such as "anticipates," "assuming," "believes," "can," "continues," "estimates," "expects," "focus," "guides," "looking ahead," "may," "plan," "opportunity," "outlook," "potential," "strategy," "will," and other similar words. All statements addressing operating performance, events or developments that Transcat expects or anticipates will occur in the future, including but not limited to statements relating to anticipated revenue, profit margins, sales operations, capital expenditures, cash flows, operating income, growth strategy, segment growth, potential acquisitions, integration of acquired businesses, market position, customer preferences, outlook and changes in market conditions in the industries in which Transcat operates are forward-looking statements. Forward-looking statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties include those more fully described in Transcat’s Annual Report and Quarterly Reports filed with the Securities and Exchange Commission, including under the heading entitled "Risk Factors." Should one or more of these risks or uncertainties materialize or should any of the Company’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company’s forward-looking statements, which speak only as of the date they are made. Except as required by law, the Company disclaims any obligation to update, correct or publicly announce any revisions to any of the forward-looking statements contained in this news release, whether as the result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260622648119/en/
Investor Relations
Chris Tyson
Executive Vice President
MZ Group - MZ North America
Phone: (949) 491-8235
TRNS@mzgroup.us
www.mzgroup.us